Gene, Cell and Tissue

Published by: Kowsar

Immunohistochemical Expression of p53 and Ki-67 Genes in Gastric Cancer and Precancerous Lesions in the Patients with Helicobacter pylori Infection

Hamidreza Mahmoudzadeh Sagheb 1 , 2 , Zahra Heidari 1 , 2 , Mehdi Jahantigh 3 and Mahdieh Narouei 2 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Department of Pathology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • Gene, Cell and Tissue: October 01, 2016, 3 (4); e41341
  • Published Online: August 27, 2016
  • Article Type: Research Article
  • Received: August 8, 2016
  • Revised: August 21, 2016
  • Accepted: August 21, 2016
  • DOI: 10.17795/gct-41341

To Cite: Mahmoudzadeh Sagheb H, Heidari Z, Jahantigh M, Narouei M. Immunohistochemical Expression of p53 and Ki-67 Genes in Gastric Cancer and Precancerous Lesions in the Patients with Helicobacter pylori Infection, Gene Cell Tissue. 2016 ; 3(4):e41341. doi: 10.17795/gct-41341.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol. 2005; 91(4): 243-52[DOI][PubMed]
  • 2. Poteca T, Poteca A, Sajin M, Comanescu M. Biological prognostic parameters in gastric carcinomas. Chirurgia (Bucur). 2014; 109(3): 347-54[PubMed]
  • 3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90[DOI][PubMed]
  • 4. Pinto-de-Sousa J, Silva F, David L, Leitao D, Seixas M, Pimenta A, et al. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology. 2004; 44(4): 323-31[DOI][PubMed]
  • 5. Matysiak-Budnik T, Megraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer. 2006; 42(6): 708-16[DOI][PubMed]
  • 6. Mashhadi M, Nazem K, Abdollahinejad MJ. Gastric Cancer in South East of Iran. Int J Hematol Oncol Stem Cell Res. 2009; 3(4): 38-42
  • 7. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986; 8: 1-27[PubMed]
  • 8. Kulmambetova GN, Imanbekova MK, Logvinenko AA, Sukashev AT, Filipenko ML, Ramanculov EM. Association of cytokine gene polymorphisms with gastritis in a Kazakh population. Asian Pac J Cancer Prev. 2014; 15(18): 7763-8[PubMed]
  • 9. Strehl JD, Hoegel J, Hornicek I, Hartmann A, Riener MO. Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa. Int J Clin Exp Pathol. 2014; 7(5): 2091-101[PubMed]
  • 10. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005; 11(6): 791-6[PubMed]
  • 11. Shadifar M, Ataee R, Ataie A, Heydari Gorgi AM, Nasri Nasrabadi N, Nouri S. Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma. Gastroenterol Hepatol Bed Bench. 2015; 8: 15-22[PubMed]
  • 12. Wroblewski LE, Peek RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010; 23(4): 713-39[DOI][PubMed]
  • 13. Hegazi A, Hassan E, El-Atrebi KA, El-Bassyouni HT. P53 protein and Ki-67 expression in chronic gastritis patients with positive Helicobacter pylori infection. J Genetic Engin Biotechnol. 2011; 9(1): 73-6
  • 14. Gucin Z, Cakmak T, Bayyurt N, Salih B. Helicobacter pylori infection and relationship with gastric epithelial cell proliferation and apoptosis. Turk J Med Sci. 2013; 43: 739-46[DOI]
  • 15. Kayacetin S, Guresci S. What is gastritis? What is gastropathy? How is it classified? Turk J Gastroenterol. 2014; 25(3): 233-47[DOI][PubMed]
  • 16. Zheng Y, Wang L, Zhang JP, Yang JY, Zhao ZM, Zhang XY. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. World J Gastroenterol. 2010; 16(3): 339-44[PubMed]
  • 17. Erkan G, Gonul ,I, Kandilci U, Dursun A. Evaluation of apoptosis along with BCL-2 and Ki-67 expression in patients with intestinal metaplasia. Pathol Res Pract. 2012; 208(2): 89-93[DOI][PubMed]
  • 18. Zullo A, Hassan C, Romiti A, Giusto M, Guerriero C, Lorenzetti R, et al. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol. 2012; 4(3): 30-6[DOI][PubMed]
  • 19. Shin N, Jo HJ, Kim WK, Park WY, Lee JH, Shin DH, et al. Gastric pit dysplasia in adjacent gastric mucosa in 414 gastric cancers: prevalence and characteristics. Am J Surg Pathol. 2011; 35(7): 1021-9[DOI][PubMed]
  • 20. Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell. 2007; 12(4): 303-12[DOI][PubMed]
  • 21. Heidari Z, Mahmoudzade Sagheb H, Asemi Rad A, Keikhaee MA. Immunocytochemical Study of p53 Protein in Exfoliated Cells of Oral Mucosa in Patients With Type 2 Diabetes. Gene Cell Tissue. 2015; 2(1)
  • 22. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997; 88(3): 323-31[PubMed]
  • 23. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54(18): 4855-78[PubMed]
  • 24. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! J Pathol. 1994; 172(1): 1-4[DOI][PubMed]
  • 25. Soussi T. p53 alterations in human cancer: more questions than answers. Oncogene. 2007; 26(15): 2145-56[DOI][PubMed]
  • 26. Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, et al. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res. 1991; 51(21): 5800-5[PubMed]
  • 27. Inwald EC, Klinkhammer-Schalke M, Hofstadter F, Zeman F, Koller M, Gerstenhauer M, et al. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat. 2013; 139(2): 539-52[DOI][PubMed]
  • 28. Niimi C, Goto H, Ohmiya N, Niwa Y, Hayakawa T, Nagasaka T, et al. Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma. Am J Clin Pathol. 2002; 118(5): 683-92[DOI][PubMed]
  • 29. Lazar D, Taban S, Sporea I, Dema A, Cornianu M, Lazar E, et al. Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up. Rom J Morphol Embryol. 2010; 51(4): 655-61[PubMed]
  • 30. Forones NM, Carvalho AP, Giannotti-Filho O, Lourenco LG, Oshima CT. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq Gastroenterol. 2005; 42(1): 30-4[PubMed]
  • 31. Sanaat Z, Halimi M, Ghojezadeh M, Pirovi AH, Gharamaleki JV, Ziae AE, et al. Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran. Int J Hematol Oncol Stem Cell Res. 2013; 7(3): 15-20[PubMed]
  • 32. Tiwari E, Pallipady A, Misra R, Mishra S. P53 and ki67 Immunostaining in Gastric Biopsies: A Histopathological Study. Int J Sci Stud. 2(11): 96-101
  • 33. Chatzipantelis P, Konstantinou P, Voros D, Smyrniotis V, Kondi-Pafiti A. Apoptosis and gastric carcinogenesis: Immunohistochemical analysis of Bax and Bcl-2 proteins. Annals of Gastroenterology. 2007; 20(2)
  • 34. Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol. 2001; 7(6): 779-82[PubMed]
  • 35. Yang Z, Shu X, Chen L, Chen J, Xie Y, Lu NH. Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: implications in gastric carcinogenesis. Clin Res Hepatol Gastroenterol. 2012; 36(3): 235-43[DOI][PubMed]
  • 36. Salih BA, Gucin Z, Bayyurt N. A study on the effect of Helicobacter pylori infection on p53 expression in gastric cancer and gastritis tissues. J Infect Dev Ctries. 2013; 7(9): 651-7[DOI][PubMed]
  • 37. Li JH, Shi XZ, Lv S, Liu M, Xu GW. Effect of Helicobacter pylori infection on p53 expression of gastric mucosa and adenocarcinoma with microsatellite instability. World J Gastroenterol. 2005; 11(28): 4363-6[PubMed]
  • 38. Morales-Fuentes GA, Zarate-Osorno A, Quinonez-Urrego EE, Antonio-Manrique M, Martinez-Garcia CL, Figueroa-Barojas P, et al. [p53 expression in the gastric mucosa of patients infected with Helicobacter pylori]. Rev Gastroenterol Mex. 2013; 78(1): 12-20[DOI][PubMed]
  • 39. Kubicka S, Claas C, Staab S, Kuhnel F, Zender L, Trautwein C, et al. p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis. Dig Dis Sci. 2002; 47(1): 114-21[PubMed]
  • 40. Berloco P, Russo F, Cariola F, Gentile M, Giorgio P, Caruso ML, et al. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma. J Gastroenterol. 2003; 38(1): 28-36[DOI][PubMed]
  • 41. Kodama M, Fujioka T, Murakami K, Okimoto T, Sato R, Watanabe K, et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol. 2005; 20(6): 941-6[DOI][PubMed]
  • 42. Jang TJ, Kim JR. Proliferation and apoptosis in gastric antral epithelial cells of patients infected with Helicobacter pylori. J Gastroenterol. 2000; 35(4): 265-71[PubMed]
  • 43. Cabral MM, Oliveira CA, Mendes CM, Guerra J, Queiroz DM, Rocha GA, et al. Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites. Scand J Gastroenterol. 2007; 42(5): 545-54[DOI][PubMed]
  • 44. Hoshi T, Sasano H, Kato K, Ohara S, Shimosegawa T, Toyota T, et al. Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis. Hum Pathol. 1999; 30(12): 1412-7[PubMed]
  • 45. Petersson F, Borch K, Franzen LE. Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection. Dig Dis Sci. 2002; 47(7): 1558-66[PubMed]
  • 46. Sasaki A, Kitadai Y, Ito M, Sumii M, Tanaka S, Yoshihara M, et al. Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol. 2003; 38(2): 153-8[PubMed]
  • 47. Van De Bovenkamp JH, Korteland-Van Male AM, Buller HA, Einerhand AW, Dekker J. Infection with Helicobacter pylori affects all major secretory cell populations in the human antrum. Dig Dis Sci. 2005; 50(6): 1078-86[PubMed]
  • 48. de Freitas D, Urbano M, Goulao MH, Donato MM, Baldaia C, Martins MI, et al. The effect of Helicobacter pylori infection on apoptosis and cell proliferation in gastric epithelium. Hepatogastroenterology. 2004; 51(57): 876-82[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments